Initial molecular studies indicate that EMP2 enhances the invasiveness and metastatic tendencies of HCC cells by activating integrins and implementing a bidirectional regulatory mechanism, processes that are intricately linked to the autophagy triggered by EMP2. The gene discussed is EMP2; the disease is hepatocellular carcinoma.